Patents Assigned to Diverse Biotech, Inc.
  • Conjugate molecules
    Patent number: 11877988
    Abstract: This disclosure provides multifunctional conjugate molecules comprising a target binding component covalently linked to one or more cannabinoids and/or one or more cannabinoid conjugate components. In some embodiments, the target binding component also is covalently linked to one or more active agent components. The disclosed conjugate molecules are designed to deliver therapeutic benefits of each component of the conjugate molecules and can be used to treat cancer and other disorders.
    Type: Grant
    Filed: June 24, 2020
    Date of Patent: January 23, 2024
    Assignee: Diverse Biotech, Inc.
    Inventors: Paul Hershberger, Philip Arlen
  • Conjugate Molecules
    Publication number: 20230173079
    Abstract: This disclosure provides multifunctional conjugate molecules comprising a target binding component covalently linked to one or more cannabinoids and/or one or more cannabinoid conjugate components. In some embodiments, the target binding component also is covalently linked to one or more active agent components. The disclosed conjugate molecules are designed to deliver therapeutic benefits of each component of the conjugate molecules and can be used to treat cancer and other disorders.
    Type: Application
    Filed: June 24, 2020
    Publication date: June 8, 2023
    Applicants: Diverse Biotech, Inc., Diverse Biotech, Inc.
    Inventors: Paul Hershberger, Philip Arlen
  • Novel Cannabinoids Formulations and Their Use for the Treatment of Acute Flaccid Myelitis
    Publication number: 20230157992
    Abstract: The present disclosure describes methods of treating acute flaccid myelitis (AFM) with one or more cannabinoids, as well as formulations and composition containing one or more cannabinoids and at least on excipient and their use for the treatment of AFM.
    Type: Application
    Filed: February 8, 2021
    Publication date: May 25, 2023
    Applicant: Diverse Biotech, Inc.
    Inventors: Philip Arlen, Stella K. Vnook
  • Cannabinoid Conjugate Molecules
    Publication number: 20220378922
    Abstract: This disclosure provides multifunctional conjugate molecules in which at least one therapeutic agent is covalently attached to a cannabinoid. The disclosed conjugate molecules are designed to deliver therapeutic benefits of both components, with release of the cannabinoid upon binding of the therapeutic agent component to its target conveying further therapeutic benefits, and can be used to treat cancer, glaucoma, confusion or dementia, and other disorders.
    Type: Application
    Filed: June 24, 2020
    Publication date: December 1, 2022
    Applicant: Diverse Biotech, Inc.
    Inventors: Paul Hershberger, Philip Arlen